Results

The eRulemaking Program

01/07/2024 | Press release | Distributed by Public on 02/07/2024 00:48

Attachment 6 Suitability Petition Approval Letter for Griseofulvin ultramicrosize oral suspension 250 mg/5 mL (Docket No. FDA 2008 P 0303)